Marc Rubenstein > Ropes & Gray LLP > Boston, United States > Lawyer Profile

Ropes & Gray LLP has long been a lead player in the private equity fund space, though the firm also has a good track record advising emerging companies on the full range of issues. The team has been especially active for life sciences companies and advised Camp4 Therapeutics in its $100 million Series B financing. Venture capital funds naturally form a large part of the overall workload, and the firm is popular with funds, such as BlueYard Crypto, that target niche assets. Boston-based partners Marc Rubenstein and Brad Flint jointly lead the team, with strong input from Melissa Bender in San Francisco, who leads the firm’s crypto blockchain taskforce.

The team at Ropes & Gray LLP provides a diverse offering to biotech startups, biopharmaceutical companies, and private equity investors. The practice handles the full gamut of issues concerning IP asset protection, and research funding. Marc Rubenstein and Michael Beauvais jointly lead the Boston based group. Rubenstein frequently represents pharmaceutical, biotech, and medical device corporates in private securities offerings; while Christopher Comeau acts for investors and public companies in minority investment transactions and private mergers within the medical tech industry. Kellie Combs continues to assist biotech companies with regulatory and compliance issues.